{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T06:39:35Z","timestamp":1792823975959,"version":"4.5.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFC2507803"],"award-info":[{"award-number":["2023YFC2507803"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82570168"],"award-info":[{"award-number":["82570168"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82130008"],"award-info":[{"award-number":["82130008"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82400157"],"award-info":[{"award-number":["82400157"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82430006"],"award-info":[{"award-number":["82430006"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82230004"],"award-info":[{"award-number":["82230004"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Beijing Natural Science Foundation","doi-asserted-by":"publisher","award":["7242154"],"award-info":[{"award-number":["7242154"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Beijing Natural Science Foundation","doi-asserted-by":"publisher","award":["L258026"],"award-info":[{"award-number":["L258026"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Beijing Natural Science Foundation","doi-asserted-by":"publisher","award":["7232188"],"award-info":[{"award-number":["7232188"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Beijing Natural Science Foundation","doi-asserted-by":"publisher","award":["L248044"],"award-info":[{"award-number":["L248044"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.canlet.2026.218883","type":"journal-article","created":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:25:53Z","timestamp":1791473153000},"page":"218883","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["GAMMA: A genetic\u2013clinical prognostic model for risk stratification in patients with relapsed\/refractory acute myeloid leukemia receiving allogeneic hematopoietic stem cell transplantation"],"prefix":"10.1016","volume":"661","author":[{"given":"Yue","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuoyu","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haixia","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dingming","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8548-2832","authenticated-orcid":false,"given":"Xi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nainong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengcheng","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shifeng","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruize","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjie","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianqian","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xufei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueqian","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoning","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunya","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyang","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiusha","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chencong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingjun","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanping","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4730-256X","authenticated-orcid":false,"given":"Xiaohui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.canlet.2026.218883_bib1","doi-asserted-by":"crossref","first-page":"i3","DOI":"10.1093\/annonc\/mdl443","article-title":"Epidemiology of hematological malignancies","volume":"18","author":"Rodriguez-Abreu","year":"2007","journal-title":"Ann. Oncol."},{"issue":"12","key":"10.1016\/j.canlet.2026.218883_bib2","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1182\/blood.2022016867","article-title":"Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN","volume":"140","author":"Dohner","year":"2022","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.canlet.2026.218883_bib3","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1182\/blood.2023022481","article-title":"How I treat refractory and relapsed acute myeloid leukemia","volume":"143","author":"Thol","year":"2024","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.canlet.2026.218883_bib4","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s13045-021-01159-2","article-title":"The consensus from the Chinese society of hematology on indications, conditioning regimens and donor selection for allogeneic hematopoietic stem cell transplantation: 2021 update","volume":"14","author":"Zhang","year":"2021","journal-title":"J. Hematol. Oncol."},{"issue":"6","key":"10.1016\/j.canlet.2026.218883_bib5","doi-asserted-by":"crossref","DOI":"10.1097\/HS9.0000000000000572","article-title":"Treatment for relapsed\/refractory acute myeloid leukemia","volume":"5","author":"Thol","year":"2021","journal-title":"HemaSphere"},{"issue":"6","key":"10.1016\/j.canlet.2026.218883_bib6","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1038\/s41375-022-01574-5","article-title":"Utility of the treatment-related mortality (TRM) score to predict outcomes of adults with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation","volume":"36","author":"Zarling","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.canlet.2026.218883_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2026.218287","article-title":"Acute myocardial infarction following allogeneic hematopoietic stem cell transplantation: a national cohort study","volume":"642","author":"Zhao","year":"2026","journal-title":"Cancer Lett."},{"issue":"26","key":"10.1016\/j.canlet.2026.218883_bib8","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1182\/blood.2021013626","article-title":"Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD working party","volume":"138","author":"Heuser","year":"2021","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.canlet.2026.218883_bib9","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1002\/cncr.30536","article-title":"Allogeneic transplantation for advanced acute myeloid leukemia: the value of complete remission","volume":"123","author":"Weisdorf","year":"2017","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.canlet.2026.218883_bib10","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1200\/JCO.2015.63.3826","article-title":"Allogeneic hematopoietic cell transplantation for acute Myeloid leukemia: time to move toward a minimal residual disease-based definition of complete remission?","volume":"34","author":"Araki","year":"2016","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.canlet.2026.218883_bib11","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/ajh.27126","article-title":"Effect of donor age in patients with acute myeloid leukemia undergoing haploidentical hematopoietic cell transplantation vary by conditioning intensity and recipient age","volume":"99","author":"Saliba","year":"2024","journal-title":"Am. J. Hematol."},{"issue":"8","key":"10.1016\/j.canlet.2026.218883_bib12","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1182\/blood-2005-05-2004","article-title":"Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT","volume":"106","author":"Sorror","year":"2005","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.canlet.2026.218883_bib13","doi-asserted-by":"crossref","first-page":"420","DOI":"10.3324\/haematol.2022.281585","article-title":"Relative impact of residual cytogenetic abnormalities and flow cytometric measurable residual disease on outcome after allogeneic hematopoietic cell transplantation in adult acute myeloid leukemia","volume":"108","author":"Orvain","year":"2023","journal-title":"Haematologica"},{"issue":"11","key":"10.1016\/j.canlet.2026.218883_bib14","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1182\/blood.2022015850","article-title":"International Consensus classification of Myeloid Neoplasms and acute Leukemias: integrating morphologic, clinical, and genomic data","volume":"140","author":"Arber","year":"2022","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.canlet.2026.218883_bib15","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s13045-017-0502-3","article-title":"Haploidentical allograft is superior to matched sibling donor allograft in eradicating pre-transplantation minimal residual disease of AML patients as determined by multiparameter flow cytometry: a retrospective and prospective analysis","volume":"10","author":"Chang","year":"2017","journal-title":"J. Hematol. Oncol."},{"issue":"8","key":"10.1016\/j.canlet.2026.218883_bib16","doi-asserted-by":"crossref","DOI":"10.1038\/bcj.2013.27","article-title":"Defining consensus leukemia-associated immunophenotypes for detection of minimal residual disease in acute myeloid leukemia in a multicenter setting","volume":"3","author":"Feller","year":"2013","journal-title":"Blood Cancer J."},{"issue":"8","key":"10.1016\/j.canlet.2026.218883_bib17","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.bbmt.2014.04.012","article-title":"Total body irradiation and cyclophosphamide plus antithymocyte globulin regimen is well tolerated and promotes stable engraftment as a preparative regimen before T cell-replete haploidentical transplantation for acute leukemia","volume":"20","author":"Fu","year":"2014","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"8","key":"10.1016\/j.canlet.2026.218883_bib18","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1182\/blood-2005-05-2146","article-title":"Conditioning including antithymocyte globulin followed by unmanipulated HLA-mismatched\/haploidentical blood and marrow transplantation can achieve comparable outcomes with HLA-identical sibling transplantation","volume":"107","author":"Lu","year":"2006","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.canlet.2026.218883_bib19","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/sj.bmt.1705445","article-title":"Haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion for the treatment of hematological malignancies","volume":"38","author":"Huang","year":"2006","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.canlet.2026.218883_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217264","article-title":"Consensus on the monitoring, treatment, and prevention of leukaemia relapse after allogeneic haematopoietic stem cell transplantation in China: 2024 update","volume":"605","author":"Wang","year":"2024","journal-title":"Cancer Lett."},{"issue":"7","key":"10.1016\/j.canlet.2026.218883_bib21","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/s41409-023-01979-5","article-title":"A novel risk model for predicting early relapse in acute myeloid leukemia patients undergoing allogeneic hematopoietic stem-cell transplantation","volume":"58","author":"Yuan","year":"2023","journal-title":"Bone Marrow Transplant."},{"issue":"8","key":"10.1016\/j.canlet.2026.218883_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2025.113077","article-title":"A molecular-based risk score for predicting leukemia-free survival in adult AML patients undergoing Allo-HSCT","volume":"28","author":"Li","year":"2025","journal-title":"iScience"},{"key":"10.1016\/j.canlet.2026.218883_bib23","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.jare.2024.09.014","article-title":"A novel prognostic scoring system for AML patients undergoing allogeneic hematopoietic stem cell transplantation with real world validation","volume":"73","author":"Wang","year":"2025","journal-title":"J. Adv. Res."},{"issue":"3","key":"10.1016\/j.canlet.2026.218883_bib24","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1515\/jtim-2025-0028","article-title":"Artificial intelligence-based predictive model for relapse in acute myeloid leukemia patients following haploidentical hematopoietic cell transplantation","volume":"13","author":"Fan","year":"2025","journal-title":"J. Transl. Int. Med."},{"issue":"11","key":"10.1016\/j.canlet.2026.218883_bib25","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1038\/s41375-019-0494-9","article-title":"Prognostic index for patients with relapsed or refractory acute myeloid leukemia who underwent hematopoietic cell transplantation: a KSGCT multicenter analysis","volume":"33","author":"Tachibana","year":"2019","journal-title":"Leukemia"},{"issue":"9","key":"10.1016\/j.canlet.2026.218883_bib27","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/s41408-021-00557-6","article-title":"Predictors of outcomes in adults with acute myeloid leukemia and KMT2A rearrangements","volume":"11","author":"Issa","year":"2021","journal-title":"Blood Cancer J."},{"issue":"7954","key":"10.1016\/j.canlet.2026.218883_bib28","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1038\/s41586-023-05812-3","article-title":"The menin inhibitor revumenib in KMT2A-rearranged or NPM1-mutant leukaemia","volume":"615","author":"Issa","year":"2023","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.canlet.2026.218883_bib29","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1182\/bloodadvances.2024014499","article-title":"TP53-mutant variant allele frequency and cytogenetics determine prognostic groups in MDS\/AML for transplantation","volume":"9","author":"Lontos","year":"2025","journal-title":"Blood Adv."},{"key":"10.1016\/j.canlet.2026.218883_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216767","article-title":"TP53 in MDS and AML: biological and clinical advances","volume":"588","author":"Zhao","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2026.218883_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217614","article-title":"Targeting p53 for immune modulation: exploring its functions in tumor immunity and inflammation","volume":"617","author":"Wu","year":"2025","journal-title":"Cancer Lett."},{"issue":"9","key":"10.1016\/j.canlet.2026.218883_bib32","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1038\/s41375-025-02672-w","article-title":"Impact of TP53 variants and germline mutations on allogeneic stem cell transplantation outcomes in acute myeloid leukemia and myelodysplastic neoplasms","volume":"39","author":"Zhao","year":"2025","journal-title":"Leukemia"},{"key":"10.1016\/j.canlet.2026.218883_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.218011","article-title":"TP53-agnostic lethality through combined pan-HDAC and CDK inhibition in acute myeloid leukemia","volume":"633","author":"Pottier","year":"2025","journal-title":"Cancer Lett."},{"issue":"19","key":"10.1016\/j.canlet.2026.218883_bib34","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1182\/blood.2025028730","article-title":"Disease risk but not remission status determines transplant outcomes in AML: long-term outcomes of the ASAP trial","volume":"146","author":"Stelljes","year":"2025","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.canlet.2026.218883_bib35","doi-asserted-by":"crossref","first-page":"e324","DOI":"10.1016\/S2352-3026(24)00065-6","volume":"11","author":"Stelljes","year":"2024","journal-title":"Lancet Haematol."},{"issue":"24","key":"10.1016\/j.canlet.2026.218883_bib36","doi-asserted-by":"crossref","first-page":"6117","DOI":"10.1182\/bloodadvances.2020002811","article-title":"Prognostic impact of complete remission with MRD negativity in patients with relapsed or refractory AML","volume":"4","author":"Short","year":"2020","journal-title":"Blood Adv."},{"key":"10.1016\/j.canlet.2026.218883_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.218063","article-title":"Developmental checkpoint targeting: Pre-TCR immunotherapy in leukemia and beyond","author":"Ma","year":"2025","journal-title":"Cancer Lett."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526006476?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526006476?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T06:21:50Z","timestamp":1792822910000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383526006476"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":36,"alternative-id":["S0304383526006476"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218883","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GAMMA: A genetic\u2013clinical prognostic model for risk stratification in patients with relapsed\/refractory acute myeloid leukemia receiving allogeneic hematopoietic stem cell transplantation","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218883","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"218883"}}